CCL2 and Bartsocas-Papas syndrome 1: One retrospective study further revealed that the lower urinary levels of the regulated upon activation, normal T cell expressed, and presumably secreted (RANTES), 8-isoprostane, macrophage chemoattractant protein-1 (MCP-1), and 8-hydroxy-2-deoxyguanosine (8-OHdG) could predict satisfactory treatment outcomes in IC/BPS patients [9].